Biontech Vaccine - Search News

What to Know About Novavax, the 'Other' COVID Vaccine

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Free COVID-19 vaccines may be harder to find this fall

Updated COVID-19 vaccines are now widely available at many pharmacies, but for New Mexicans who lack insurance, the wait will be longer and supplies less certain. The New Mexico Department of Health expects to distribute some 6,

Northwest Asian Weekly · 3d

Fight off the virus this fall with a 2024-2025 COVID-19 vaccine

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Mayo Clinic on MSN · 1d

COVID-19 vaccines: Get the facts

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to

3don MSN

BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

EuropaWire1d

Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Pfizer, BioNTech's Omicron-Adapted Covid-19 Vaccine Gets E.U. Marketing Recommendation

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

Armed robbery in Revesby2d

Pfizer/BioNTech Get CHMP Nod for Omicron KP.2 EU Vaccine

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...

11d

BioNTech's Low Valuation, Many Shots On Goal Make It A Buy

BioNTech shares surged 13% after Summit Therapeutics reported positive data on ivonescimab. Find out why BNTX stock is a Buy.

BioSpace6d

5 Late-Stage mRNA Vaccines to Watch

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

5don MSN

BioNTech raised to buy at Jefferies on new cancer drug

BioNTech (BNTX) stock traded higher on Tuesday after Jefferies upgraded the COVID-19 vaccine maker to Buy, citing the ...

Newsable Asianet News on MSN2d

Fresh hopes in cancer treatment: New vaccine shows promise in early trials

A new cancer vaccine, mRNA-4359, utilizing mRNA technology similar to Covid-19 vaccines, has yielded encouraging results in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results